Microbot Medical Inc. (MBOT) stock forecast and price target
Price $0.98 · data as of November 13, 2026
12-month price target
Average target$5.38
Upside / downside+449.2%
Analysts4
ConsensusNone
Low $2.50Average $5.38High $12.00
Gold marker: average target · white marker: today’s price ($0.98)
Analyst ratings
Strong buy 1Buy 3Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.30 | −5.2% | $1M |
| Next fiscal year ends December 31, 2027 | $-0.32 | −4.9% | $6M |
| Next quarter ends December 31, 2026 | $-0.09 | −112.5% | $575000 |
| Quarter after ends March 31, 2027 | $-0.08 | −60.0% | $666670 |
Consensus of the analysts covering Microbot Medical, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Frequently asked questions
What is the Microbot Medical stock price target?
The average 12-month target from 4 analysts is $5.38, 449.2% above the current price of $0.98 Targets range from $2.50 to $12.00.
Is Microbot Medical a buy according to analysts?
The consensus rating is “None” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Microbot Medical expected to earn?
Analysts expect EPS of $-0.30 for the fiscal year ending December 31, 2026 and $-0.32 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.